跳至主要内容
临床试验/DRKS00024434
DRKS00024434尚未招募不适用

Immune-mediated pathogenesis and development of autoimmunity in neurological manifestations of COVID-19 - IPEA

niversity of Cologne0 个研究点目标入组 150 人开始时间: 2021年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Informed consent
  • no drug or alcohol addiction
  • german language

排除标准

  • not able to give informed consent, under-age, no juristical supervisor

研究者

发起方
niversity of Cologne

相似试验

已完成
不适用
The role of innate immunity in the pathogenesis of acute respiratory syncytial virus lower respiratory tract infection: Repeated measurements of nasopharyngeal type 1 interferon levels in RSV infectionsInnate immune responseViral respiratory tract infection10024970
NL-OMON35329RSV Research Group van het Wilhelmina Kinderziekenhuis Utrecht, UMCU, onder leiding van Prof. dr. J.L.L. Kimpen, promotor400
尚未招募
2 期
Examinations for immune-biological mechanism of anti-atherosclerotic effects of omega 3 lipid formula, Lotriga, focusing on commensal microbe and serum auto-antibodies.The subjects with hyper-triglyceridemia and atherosclerosis.
JPRN-UMIN000032320Yokohama City University Graduate School of Medicine, Department of Medical Science and Cardio-Renal Medicine36
已完成
不适用
Immunogenetic and therapeutic aspects of Autoimmune Hepatitis
NL-OMON44835Vrije Universiteit Medisch Centrum2,000
进行中(未招募)
不适用
Investigation of immune mechanisms relating to lapatinib associated hepatotoxicity (liver toxicity)The subjects participated in the EGF105485 study, a randomized, placebo-controlled study of lapatinib in HER2-positive early-stage breast cancer. During participation in this study, subjects had blood test results that may be suggestive of liver damage.
EUCTR2013-000572-15-ESGlaxoSmithKline, S.A.75
进行中(未招募)
不适用
Investigation of immune mechanisms relating to lapatinib associated hepatotoxicity (liver toxicity)
EUCTR2013-000572-15-DKGlaxoSmithKline Research & Development Ltd75